VS-01 on top of SOC
Phase 2Terminated 0 views this week 0 watching💤 Quiet
Interest: 17/100
17
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Acute-On-Chronic Liver Failure
Conditions
Acute-On-Chronic Liver Failure, Ascites
Trial Timeline
Jul 2, 2023 → Oct 15, 2025
NCT ID
NCT05900050About VS-01 on top of SOC
VS-01 on top of SOC is a phase 2 stage product being developed by Genfit for Acute-On-Chronic Liver Failure. The current trial status is terminated. This product is registered under clinical trial identifier NCT05900050. Target conditions include Acute-On-Chronic Liver Failure, Ascites.
What happened to similar drugs?
0 of 1 similar drugs in Acute-On-Chronic Liver Failure were approved
Approved (0) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
12
Activity
0
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05900050 | Phase 2 | Terminated |
Competing Products
2 competing products in Acute-On-Chronic Liver Failure
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| SMT + PE-A 5% | Grifols | Phase 3 | 29 |
| Single Dose G1090N + Multiple dosing of G1090N | Genfit | Phase 1 | 19 |